Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 315

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 19
Chunk 315
---
. As a result, all Ordinary
shares, Convertible Preferred shares, options for Ordinary Shares, warrants to Ordinary shares and Preferred shares, exercise price and
net loss per share amounts were adjusted accordingly.

Ordinary shares
rights

The Ordinary shares
confer upon their holders the right to participate in the general meetings of the Company, to vote at such meetings (each share representsonevote), and to participate in any distribution of dividends or any other distribution of the Company’s property, including the distribution
of surplus assets upon liquidation.

  Share option plans:  

The Company has authorized
through its 2021 Share Option Plan (the “ Plan”), an available pool of Ordinary shares of the Company from which to grant options
and RSUs to officers, directors, advisors, management and other key employees of up to20,979,410Ordinary shares as of December 31, 2024.

The options granted
generally have afour-year vesting period and expireten
yearsafter the date of grant, subject to the terms set forth in the Plan. Options
granted under the Plan that are cancelled or forfeited before expiration become available for future grant.

As of December 31,
2024,11,383,655of the Company’s Ordinary shares are available for future grants.

F-25

ALPHA TAU MEDICAL
LTD. AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS

U. S. dollars
in thousands (except share and per share data)

NOTE 12:- SHAREHOLDERS’ (DEFICIENCY) EQUITY (Cont.)

A summary of the
status of options under the Company’s share option plans as of December 31, 2024 and changes during the relevant period ended
on that date is presented below:

                                        For the year ended December 31, 2024                                                                              
                                        Number                                                    Weighted      Aggregate intrinsic                       
                                                                                                                                                          
                                        of options                                                 average      value                                     
                                                                                                                                                          
                                                                                                  exercise                                                
                                                                                                                                                          
                                                                                                     price                                                
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Outstanding at beginning of year                                                10,520,774         $5.03      $                        2,264      7.08  
  Granted                                                                          4,170,370         $3.60                                                
  Exercised                                                                         ( 22,602         $1.10      $                           39